P3 Health Partners Inc. (NASDAQ:PIII) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET

Company Participants

Karen Blomquist - Vice President, Investor Relations

Sherif Abdou - Chief Executive Officer & Co-Founder

Atul Kavthekar - Chief Financial Officer

Amir Bacchus - Chief Medical Officer

Conference Call Participants

Brooks O'Neil - Lake Street Capital Markets

Ryan Daniels - William Blair

Josh Raskin - Nephron Research

Gary Taylor - Cowen

Operator

Good afternoon, everyone, and welcome to the P3 Health Partners First Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded.

I will now turn the call over to Karen Blomquist, Vice President, Investor Relations of P3. Please go ahead.

Karen Blomquist

Thank you, operator, and thank you for joining us today. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under the US Federal Securities laws, including statements regarding our financial outlook and long-term targets.

These forward-looking statements are only predictions and are based solely on our current expectations and projections about future events and financial trends that we believe may affect our business financial condition and results of operations. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. Additional information concerning factors that could cause actual results to differ from statements made on this call is contained in our periodic reports filed with the SEC.

The forward-looking statements made during this call, speak only as of the date hereof and the company undertakes no obligation to update or revise the forward-looking statements. We will refer to certain non-GAAP financial measures on this call. These non-GAAP financial measures are in addition to and not a substitute or superior to measures of financial performance prepared in accordance with GAAP.

There are a number of limitations related to the use of these non-GAAP financial measures. For example, other companies may calculate similarly titled non-GAAP financial measures differently. Refer to the appendix of our earnings release for a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures. Information presented on this call is contained in the press release we issued today and in our SEC filings, which may be accessed from our Investors page of the P3 Health Partners website.